Biolife Solutions (BLFS) Non Operating Income (2010 - 2026)
Biolife Solutions (BLFS) posted quarterly Non Operating Income of $1.2 million for Q1 2026, up 78.77% year-over-year from $683000.0 in Q1 2025, and down 39.4% quarter-over-quarter from $2.0 million in Q4 2025.
Biolife Solutions (BLFS) Non Operating Income (2010 - 2026) Analysis & Trends
Biolife Solutions (BLFS) has reported Non Operating Income for 17 consecutive years, with $1.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Non Operating Income rose 78.77% year-over-year to $1.2 million; the TTM figure through Mar 2026 stood at $4.7 million (up 162.74% YoY), while the FY2025 annual figure was $4.5 million, up 204.03% from the prior year.
- Non Operating Income slipped to $1.2 million in Q1 2026 per BLFS's latest filing, from $2.0 million in the prior quarter.
- Across five years, Non Operating Income topped out at $2.0 million in Q4 2025 and bottomed at -$4.3 million in Q2 2024.
- Historically, Non Operating Income has averaged -$186000.0 across 5 years, with a median of -$53000.0 in 2022.
- Annual changes were most pronounced in 2024 — Non Operating Income tumbled 4498.8% — and 2025, when it soared 587.86%.
- Biolife Solutions' Non Operating Income stood at -$34000.0 in 2022, then jumped by 344.12% to $83000.0 in 2023, then sank by 4498.8% to -$3.7 million in 2024, then jumped by 155.19% to $2.0 million in 2025, then tumbled by 39.4% to $1.2 million in 2026.
- Business Quant data shows BLFS's Non Operating Income at $1.2 million in Q1 2026, $2.0 million in Q4 2025, and $508000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 82.70 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | - |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 25.45 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | -160.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | -12.80 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | - |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 3.50 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | - |
| 10 | Biolife Solutions | 1.82 Bn | 1.73 Bn | 18.29 Mn | 1.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.06 Mn |
| Mar 31, 2026 | 1.22 Mn |
| Dec 31, 2025 | 2.02 Mn |
| Sep 30, 2025 | 508,000.00 |
| Jun 30, 2025 | 931,000.00 |
| Mar 31, 2025 | 683,000.00 |
| Dec 31, 2024 | -3.65 Mn |
| Sep 30, 2024 | -230,000.00 |
| Jun 30, 2024 | -4.25 Mn |
| Mar 31, 2024 | -140,000.00 |
| Dec 31, 2023 | 83,000.00 |
| Sep 30, 2023 | -214,000.00 |
| Jun 30, 2023 | -387,000.00 |
| Mar 31, 2023 | -411,000.00 |
| Dec 31, 2022 | -34,000.00 |
| Sep 30, 2022 | 824,000.00 |
| Jun 30, 2022 | -54,000.00 |
| Mar 31, 2022 | -53,000.00 |
| Dec 31, 2021 | 6.47 Mn |
| Sep 30, 2021 | -194,000.00 |